Skip to content

Treasury Stock at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$76.26B+0.5%
CONMED logo
CONMEDCNMD
$49.04M+238%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$9.14B+5.8%
Alphatec Holdings logo
Alphatec HoldingsATEC
$25.1M0.0%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$273.5M+274%
TFX
TeleflexTFX
$649.53M+85.4%

Other financials

Income statement

See full
Revenue$47.2M-10.2%
Gross profit$37.4M-10.7%
Operating income-$17.2M-10.2%
Net income-$18.0M-12.8%
EPS (diluted)-$0.28-12.0%

Balance sheet

See full
Cash & equivalents$9.5M-28.6%
Total debt$71.6M+3.2%
Total equity$77.2M-26.7%
Total assets$184.1M-10.6%

Cash flow

See full
Operating cash flow$7.2M+72.5%
CapEx$3.1M-13.6%
Free cash flow$4.2M+538%

Valuation

See full
Market cap$258.19M-22.3%
Enterprise value$320.25M-19.0%
P/S1.3×-0.3×

Profitability

See full
Gross margin79.7%-0.5pp
Operating margin-26.9%+2.5pp
Net margin-29.4%+6.1pp
FCF margin-12.5%-2.8pp

Returns & leverage

See full
Return on equity-66.9%+57.5pp
Debt / equity0.9×+0.3×
Current ratio3.6×-0.9×

Where this comes from

Reported directly by Treace Medical Concepts, Inc. in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockValue.

The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Treace Medical Concepts, Inc.'s treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Treace Medical Concepts, Inc.'s treasury stock?
Treace Medical Concepts, Inc. (TMCI) reported treasury stock of $1.39M in Q1 2026.
How has Treace Medical Concepts, Inc.'s treasury stock changed year-over-year?
Treace Medical Concepts, Inc.'s treasury stock increased by 103.8% year-over-year, from $682K to $1.39M.
What does treasury stock mean?
Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.